We use a few cookies

Essential cookies keep the library working. With your permission, we'd also like to use analytics to see what's useful and improve the experience. Read our Privacy Policy or Cookie Policy.

Skip to main content
Home/e-Resources/Medical Sciences/CA 15–3: A Prognostic Marker in Breast Cancer
PeriodicalsMedical Sciences

CA 15–3: A Prognostic Marker in Breast Cancer

Checking your access to this record.

Abstract & Overview

CA 15-3 (also known as MUC1) is the most widely used serum marker in breast cancer. MUC1 is a large transmembrane glycoprotein which is frequently overexpressed and aberrantly glycosylated in cancer. Physiologically, MUC1 appears to play a role in cell adhesion and the high levels present in cancer may be causally involved in metastasis. At present the main uses of CA 15-3 are in preclinically detecting recurrent breast cancer and monitoring the treatment of patients with advanced breast cancer. In a prospective study of 368 patients we show that patients with high preoperative levels of CA 15-3 (>30.4 U/mL) had a worse outcome than patients with low levels of the marker. In multivariate analysis CA 15-3 as a prognostic marker was independent of both tumor size and nodal status. Furthermore, in multivariate analysis the prognostic impact of CA 15-3 was stronger than that of tumor size and at least as strong as nodal status. CA 15-3 may thus be the first independent prognostic serum marker in breast cancer.

Cite this record

Michael Joe Duffy, Stephen G. Shering, F. Sherry, E. W. M. McDermott, N. J. O’Higgins (2000). CA 15–3: A Prognostic Marker in Breast Cancer. The International Journal of Biological Markers, 15(4), 330–333. https://doi.org/10.1177/172460080001500410

Copy in another style

Duffy, M. J., Shering, S. G., Sherry, F., McDermott, E. W. M., & O’Higgins, N. J. (2000). CA 15–3: A Prognostic Marker in Breast Cancer. The International Journal of Biological Markers, 15(4), 330–333. https://doi.org/10.1177/172460080001500410
Author names are used as deposited, so check their order before you submit.

Metadata is harvested from open-access indexes and can be incomplete. Check a citation against the published version before relying on it — see our open access & attribution policy.